TrialClinical and translational science2024

Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial.

Sarah Glewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.